What lead to the initial research on Greveton is actually a very interesting story of a man who chronically suffered from Myasthenia Gravis and went to hospitals and doctors all over the country in search of treatment, but to no avail. His desperation lead to him to take over matters in his own hands and he started to research on alternative medicine for his condition. He sourced many botanical plants and seeds from all over the world after going through numerous modern and ancient handbooks of herbal medicine. Through continuous trial and error he selected some herbs while rejecting others. Eventually he short listed those that showed some efficacy in his trials and combined them in one blend to make the basic formulation for his treatment. Not only were his symptoms relieved, he managed to get rid of Myasthenia Gravis for ever.

Equipped with his powerful discovery, he embarked upon helping others. Some how, he managed to get some small articles squeezed in local newspapers discussing the amazing success he had in treating his condition with natural botanicals.

Around that time, a group of entrepreneurs had started a company called Gordon's Herbal Research Center or GHRC. GHRC was on a mission to document the therapeutic effects of all herbal plants in order to discover products that can be patented and be suitable for marketing.

The newspaper articles caught the attention of one of the members of the company. GHRC conducted some basic tests and found the compound to be highly effective against Myasthenia Gravis. Rights for the formula were purchased from the original discoverer and the compound was named Greveton.

The company started to collect anecdotal data for formal research on Greveton and started testing it in vivo (with live animals) and in vitro (with cell culture study).

After many months of comprehensive Chemical Characterization and testing of the Greveton compound, it was declared highly effective for treatment of Myasthenia Gravis . It was concluded that the product was a novel discovery.

Toxicity studies took more than two years and indicated no toxicity whatsoever.

To date, thousands of patients have been treated with Greveton for Myasthenia Gravis with a success rate of more than 80%.